Sangu-an, Johna B.

HRN: 28-50-01  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2026
CEFUROXIME 500MG (TAB)
02/19/2026
02/26/2026
PO
500mg
BID X 7 Days
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: